JACOBIO-B News

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024

Apr 3 04:58 ET

JACOBIO-B: VOLUNTARY ANNOUNCEMENT

Mar 5 05:27 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024

Mar 4 03:40 ET

JACOBIO-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Mar 1 03:05 ET

JACOBIO-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Mar 1 02:59 ET

JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED US FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR P53 Y220C Activator JAB-30300

Feb 29 23:09 ET

JACOBIO-B: VOLUNTARY ANNOUNCEMENT THE REGISTRATIONAL PHASE III CLINICAL TRIAL OF SHP2 INHIBITOR JAB-3312 IN COMBINATION WITH KRAS G12C INHIBITOR GLECIRASIB APPROVED BY THE CENTER FOR DRUG EVALUATION (CDE) OF THE NMPA

Feb 18 06:50 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024

Feb 5 03:42 ET

JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO PRESENTED CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI

Jan 21 05:08 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023

Jan 4 03:47 ET

JACOBIO-B: NEXT DAY DISCLOSURE RETURN

Dec 22, 2023 03:38 ET

JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO TO PRESENT CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI

Dec 6, 2023 23:00 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023

Dec 4, 2023 03:43 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023

Nov 2, 2023 04:36 ET

JACOBIO-B: VOLUNTARY ANNOUNCEMENT PRESENTATION OF CLINICAL DATA OF GLECIRASIB IN COMBINATION WITH JAB-3312 AT THE 2023 ESMO CONGRESS

Oct 23, 2023 06:27 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2023

Oct 5, 2023 04:33 ET

JACOBIO-B: NEXT DAY DISCLOSURE RETURN

Sep 29, 2023 09:07 ET

JACOBIO-B: NEXT DAY DISCLOSURE RETURN

Sep 26, 2023 09:29 ET

JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2023

Sep 4, 2023 04:30 ET

JACOBIO-B: NEXT DAY DISCLOSURE RETURN

Aug 31, 2023 07:30 ET